{
    "xml": "<topic id=\"PHP85589\" outputclass=\"drug\" rev=\"1.16\" type=\"drug\" namespace=\"/drugs/dapagliflozin-with-metformin\" basename=\"dapagliflozin-with-metformin\" title=\"DAPAGLIFLOZIN WITH METFORMIN\">\n<title>DAPAGLIFLOZIN WITH METFORMIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_267\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/biguanides/metformin\">Metformin</xref>, <xref format=\"dita\" href=\"#bnf_int_1239\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/dapagliflozin\">Dapagliflozin</xref>\n</p>\r\n<p outputclass=\"constituentDrugs\">The properties listed below are those particular to the combination only. For the properties of the components please consider, <xref format=\"dita\" href=\"#PHP18937\" namespace=\"/drugs/dapagliflozin\">dapagliflozin</xref>, <xref format=\"dita\" href=\"#PHP4161\" namespace=\"/drugs/metformin-hydrochloride\">metformin hydrochloride</xref>.</p>\n<data name=\"vtmid\">24056711000001100</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_387708906\" title=\"Sodium glucose co-transporter 2 inhibitors\">Sodium glucose co-transporter 2 inhibitors</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_709441655\" title=\"Biguanides\">Biguanides</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP86752\" outputclass=\"indicationsAndDose\" rev=\"1.14\" parent=\"/drugs/dapagliflozin-with-metformin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with insulin or other antidiabetic drugs</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;74 years</p>\n<p>1&#8239;tablet twice daily, based on patient&#8217;s current metformin dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 75 years and over</p>\n<p>Initiation not recommended.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86753\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/dapagliflozin-with-metformin\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Dose of concomitant insulin or drugs that stimulate insulin secretion may need to be reduced.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86751\" outputclass=\"hepaticImpairment\" parent=\"/drugs/dapagliflozin-with-metformin\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP86765\" outputclass=\"nationalFunding\" rev=\"1.9\" parent=\"/drugs/dapagliflozin-with-metformin\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (July 2014) that dapagliflozin plus metformin (<i>Xigduo</i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland in patients for whom a combination of dapagliflozin and metformin is an appropriate choice of therapy i.e when metformin alone does not provide adequate glycaemic control and a sulfonylurea is inappropriate, <i>or</i> in combination with insulin, when insulin and metformin does not provide adequate control, <i>or</i> in combination with a sulphonylurea, when a sulfonylurea and metformin does not provide adequate control.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP85589-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/dapagliflozin-with-metformin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92239\" title=\"Tablet\" namespace=\"/drugs/dapagliflozin-with-metformin/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_267\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/biguanides/metformin\" title=\"Metformin\" count=\"1\" rel=\"link\">Metformin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1239\" namespace=\"/interactions/list-of-drug-interactions/antidiabetics/dapagliflozin\" title=\"Dapagliflozin\" count=\"1\" rel=\"link\">Dapagliflozin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP18937\" namespace=\"/drugs/dapagliflozin\" title=\"DAPAGLIFLOZIN\" count=\"1\" rel=\"link\">DAPAGLIFLOZIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP4161\" namespace=\"/drugs/metformin-hydrochloride\" title=\"METFORMIN HYDROCHLORIDE\" count=\"1\" rel=\"link\">METFORMIN HYDROCHLORIDE</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP92239\" namespace=\"/drugs/dapagliflozin-with-metformin/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP85589",
    "outputclass": "drug",
    "rev": "1.16",
    "type": "drug",
    "namespace": "/drugs/dapagliflozin-with-metformin",
    "basename": "dapagliflozin-with-metformin",
    "title": "DAPAGLIFLOZIN WITH METFORMIN",
    "interactants": [
        {
            "id": "bnf_int_267",
            "label": "Metformin"
        },
        {
            "id": "bnf_int_1239",
            "label": "Dapagliflozin"
        }
    ],
    "constituents": [
        {
            "id": "PHP18937",
            "label": "dapagliflozin"
        },
        {
            "id": "PHP4161",
            "label": "metformin hydrochloride"
        }
    ],
    "vtmid": "24056711000001100",
    "drugClassification": [
        "Sodium glucose co-transporter 2 inhibitors",
        "Biguanides"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with insulin or other antidiabetic drugs",
                        "html": "Type 2 diabetes mellitus not controlled by metformin alone or by metformin in combination with insulin or other antidiabetic drugs"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "1 tablet twice daily, based on patient&#8217;s current metformin dose.",
                        "html": "<p>1&#8239;tablet twice daily, based on patient&#8217;s current metformin dose.</p>",
                        "ageGroup": "18&#8211;74 years"
                    },
                    {
                        "textContent": "Initiation not recommended.",
                        "html": "<p>Initiation not recommended.</p>",
                        "ageGroup": "75 years and over"
                    }
                ]
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Dose of concomitant insulin or drugs that stimulate insulin secretion may need to be reduced.",
                "html": "<p>Dose of concomitant insulin or drugs that stimulate insulin secretion may need to be reduced.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (July 2014) that dapagliflozin plus metformin (Xigduo ) is accepted for restricted use within NHS Scotland in patients for whom a combination of dapagliflozin and metformin is an appropriate choice of therapy i.e when metformin alone does not provide adequate glycaemic control and a sulfonylurea is inappropriate, or in combination with insulin, when insulin and metformin does not provide adequate control, or in combination with a sulphonylurea, when a sulfonylurea and metformin does not provide adequate control.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (July 2014) that dapagliflozin plus metformin (<i>Xigduo</i> <tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland in patients for whom a combination of dapagliflozin and metformin is an appropriate choice of therapy i.e when metformin alone does not provide adequate glycaemic control and a sulfonylurea is inappropriate, <i>or</i> in combination with insulin, when insulin and metformin does not provide adequate control, <i>or</i> in combination with a sulphonylurea, when a sulfonylurea and metformin does not provide adequate control.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP92239",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_267",
                "label": "Metformin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_1239",
                "label": "Dapagliflozin",
                "type": "interaction"
            }
        ],
        "drug": [
            {
                "id": "PHP18937",
                "label": "DAPAGLIFLOZIN",
                "type": "drug"
            },
            {
                "id": "PHP4161",
                "label": "METFORMIN HYDROCHLORIDE",
                "type": "drug"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP92239",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}